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Abstract.  The integrin  family of heterodimeric  cell 
surface receptors play critical  roles in multiple  biolog- 
ical processes by mediating  cellular  adhesion to the 
extracellular  matrix  (ECM).  Adhesion triggers  intra- 
cellular  signaling  cascades,  including  tyrosine phos- 
phorylation  and elevation of [Ca2÷]i. The Focal Adhe- 
sion Kinase  (FAK or pp125F~),  a  protein tyrosine 
kinase that  colocalizes with  integrins  in cellular focal 
adhesions,  is a prime  candidate  for a  mediator  of inte- 
grin  signaling  events.  Here we report an analysis of 
the domain  structure  of FAK in which we have 
identified a  contiguous  stretch of 159 amino acids 
within the COOH terminus  essential  for correct  sub- 
cellular  localization.  When placed in the context of an 
unrelated  cytosolic protein,  this  Focal Adhesion Tar- 
geting  (FAT) sequence functions to efficiently mediate 
the focal adhesion  localization  of this  fusion protein. 
Furthermore,  this analysis suggests that pp125 F~ can- 
not be activated oncogenically by mutation.  This  result 
could be explained  if pp125 F~ either exhibits  a narrow 
substrate  specificity or is diametrically  opposed by 
cellular phosphatases  or other cellular processes. 
HESION of cells to the extracellular  matrix  (ECM) z 
is a critical step in biological processes such as de- 
velopment and differentiation,  metastasis, and nor- 
mal cell growth (Hynes,  1992). The integrin family of cell 
surface receptors play a prominent role in mediating many 
of these cellular processes.  The integrins  are heterodimers 
consisting of one c~ and/~ subunit (Albelda and Buck, 1990; 
Hynes, 1992). To date,  15 different c~ chains and 8 different 
/3 chains have been identified.  The complexity of receptor- 
ligand interactions is augmented by the fact that an individual 
integrin  receptor may bind more than one adhesive ligand 
and a particular cell may express a large repertoire of inte- 
grins.  The integrins are prominent in focal adhesions,  sub- 
cellular  structures  formed at  regions  of close contact be- 
tween the cell and its underlying substratum.  In addition to 
binding specific ECM components through their extracellu- 
lar domain, the cytoplasmic tail of the/31  integrin binds to 
at least two defined elements of the cytoskeleton, talin, and 
o~-actin (Horwitz et al.,  1986; Tapley et al.,  1989; Otey et 
al.,  1990).  These two cytoskeletal proteins  associate with 
other proteins present in focal adhesions including vinculin, 
paxillin, zyxin, and actin (Turner and Burridge,  1991; Bur- 
ridge  et  al.,  1988).  Through  these  interactions,  integrins 
serve to link the ECM to the cytoskeleton. The architecture 
Please address all correspondence to J. Thomas Parsons,  Department of 
Microbiology,  Box 441,  Health Sciences  Center,  University of Virginia, 
Charlottesville, VA 22908. 
1.  Abbreviations  used in  this paper:  CE,  chicken embryo; dl,  deletion; 
ECM, extracellular matrix; FAK, Focal Adhesion Kinase; FAT, focal adhe- 
sion targeting;  pTyr, phosphotyrosine. 
of a focal adhesion is complex and its assembly/disassembly 
appears  to be dependent  upon an  extensive array  of pro- 
tein-protein  interactions. 
Increasing evidence indicates that integrin-ligand interac- 
tions play a much greater role in biological signaling  than 
simply serving as mediators of ECM-cytoskeleton linkage. 
Engagement of integrins with defined ligands induce several 
intracellular  signals,  including  increase  in  pHi,  elevated 
[Ca2+]i levels (Jaconi,  1991;  Schwartz et al.,  1983; Richter 
et al., 1990; Pelletier et al., 1992), tyrosine phosphorylation 
of cellular proteins (Guan et al., 1991; Kornberg et al., 1991, 
1992; Golden et al., 1990), and activation ofgene expression 
(Werb et al.,  1989). The mechanisms by which integrins ini- 
tiate signal cascades are unknown, but probably employ in- 
termediary  signaling  proteins  since  integrins  themselves 
contain  no identified  intrinsic  enzymatic  activity.  The  in- 
crease in phosphotyrosine  (pTyr)-containing  proteins  trig- 
gered  by ECM-integrin  interactions  suggests  the  involve- 
ment of integrin-regulated  protein tyrosine kinases in these 
potential signaling events. Recently, we identified a 125-kD 
cytoplasmic protein  tyrosine kinase  that localizes  to focal 
adhesions  (pp125 FAK,  Focal  Adhesion  Kinase,  or  FAK) 
(Schaller et al.,  1992). The FAK protein is structurally dis- 
tinct from other identified cytoplasmic tyrosine kinases. The 
catalytic  domain  is  flanked  by  large  NH2-  and  COOH- 
terminal domains of unknown function. Neither domain ex- 
hibits significant sequence similarity to other identified pro- 
teins.  In addition,  FAK contains no SH2 or SH3 domains, 
motifs which mediate protein-protein  interactions  and are 
present in most other cytoplasmic protein tyrosine kinases 
(Pawsons and Gish,  1992). The sequence of avian, mouse, 
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is highly conserved across species (Schaller et al.,  1992; 
Hanks et al.,  1992;  Andre and Becker-Andre, 1993).  FAK 
is expressed in most cell lines and tissues examined (Hanks 
et al., 1992; Andre and Becker-Andre, 1993; Turner et al., 
1993;  Schaller, M. D., unpublished observations). In some 
cells the COOH-terminal domain of pp125 FAr is expressed 
autonomously as a 41-kD protein (called FRNK-FAK-Related- 
Non-Kinase) (Schaller et al.,  1993). 
Evidence from several laboratories has  shown that en- 
gagement of integrin with ECM ligands or cross-linking of 
surface integrins with antibodies leads to increased phos- 
phorylation of pp125 FA~ (Guan and Shalloway 1992;  Korn- 
berg et al., 1992;  Hanks et al., 1992; Schaller et al., 1993; 
Burridge et al., 1992) and a concomitant increase in pp125  P~ 
kinase activity in vitro (Guan and Shalloway,  1992).  These 
data, in conjunction with the localization of pp125 FA~ to fo- 
cal adhesions, supports the hypothesis that pp125 FAK may be 
directly involved in the transduction of signals transmitted 
through cell surface integrins. 
To understand the regulation of pp125 F^K and its potential 
role in integrin directed signaling, we have initiated an analy- 
sis of the structural domains of the FAK protein. Using a se- 
ries of FAK deletion variants, we have identified a sequence 
element(s) necessary for the localization of FAK to cellular 
focal adhesions. This sequence (termed the FAT sequence, 
for Focal Adhesion/hrgeting sequence), resides within a se- 
quence of 159 amino acids embedded in the COOH-terminal 
domain of pp125 FAK. Addition of 199 residues derived from 
the FAK COOH terminus, which contains the FAT sequence, 
to a cytosolic form of pp60  ~r~ directed its localization to fo- 
cal adhesions. Thus, the FAT sequence appears to be both 
obligatory for directing FAK to focal adhesions and suffi- 
cient to function independently as a focal adhesion localiza- 
tion domain. The role of pp125 FA~ in mediating cell signal- 
ing from the ECM is discussed. 
Materials and Methods 
Cells and Viruses 
Primary chicken embryo (CE) ceils were maintained and transfected with 
retroviral vectors as described (Reynolds et al., 1989). Replication-compe- 
tent RCASA (BH) and RCAS B (BH) retroviral vectors (Hughes et al., 1987) 
were used for the expression of FAK and Src derivatives. 
Molecular Biology 
The full length FAK eDNA was cloned into pBluescript (Stratagene,  La 
Jolla, CA) and this plasmid (pBSFAK) (Schailer et al.,  1992) was used for 
the generation of FAK variants. Deletion (dl) mutations are designated by 
the amino acid residues deleted. Base pair designation corresponds to the 
nucleotide sequences of the FAK eDNA which contains 5' untranslated se- 
quences (Schaller et al.,  1992). The mutation d13M44 was generated by 
deletion of sequences between Sinai (bp 137) and DraI (bp 479). To con- 
struct d151-377, pBSFAK was digested with BstXI (bp 200) and the resulting 
3' extension removed with T4 DNA polymerase. This blunt end was ligated 
to DNA digested with MscI (bp 1177), thus deleting nucloatides 197-1176. 
Mutation d1686-1011  was created by digesting pBSFAK with Psfl (which 
cleaves at nucleotides 2105 and 3083) followed by religation of the PstI ter- 
mini.  Mutation d1721-857  was  made by digesting pBSFAK with BstEII 
(which cleaves at bps 2208 and 2619) followed by rejoining of the BstEII 
termini. To generate d1853-963, pBSFAK was digested with ApaI (position 
2608) and the 3' extension removed by treatment with T4 DNA polymerase. 
This blunt end was ligated to a blunt end formed by digesting pBSFAK with 
NheI (position 2941)  followed by incubation with T4 DNA  polymerase 
to  fill  in  the  5' extension.  The  resulting  deletion  removes  nucleotides 
2605-2936.  The mutation d1965-1012  was created by digesting pBSFAK 
with NheI (bp 2941) and EcoNI (bp 3083), followed by incubation with T4 
DNA polymerase and T4 DNA ligase, to modify the termini and ligate the 
blunt ends. The resulting mutation deletes nucleotides 2944-3081.  In the 
process of ganerating d1965-1012,  a new codon was created, such that a glu- 
tamic acid to alanine substitution occurred at position 965. 
The point mutation pmK454R (Lys  454 to Arg) was generated by oligo- 
nucleotide-directed mutaganesis,  pBSFAK was used to transform CJ236 
E. coli (Biorad Labs., Hercules, CA), a strain which allows for uracil incor- 
poration  into  DNA.  Mutagenic  primers  were  annealed  to  the  single- 
stranded template isolated from CJ236 and second strand synthesis was car- 
ried out in vitro using T4 DNA polymerase. In vitro synthesized DNA was 
transformed into an E. coli strain which selects against the DNA strand con- 
taining uracil (MVll90, Biorad Labs.). Clones were isolated and analyzed 
by dideoxy DNA sequencing (Un.  States Biochem., Cleveland, OH). 
The plasmid  constructs  encoding  the  fusion proteins  2ASrcFAT  and 
2ASrcFATdl were generated as follows.  Using PCR, the eDNA encoding 
a variant of plRi0  c-s~ containing a glycine to alanine substitution at residue 
2 was amplified and an Apal restriction site created at nucleotide position 
1551. The amplified eDNA was iigated in frame to the ApaI site in the FAK 
eDNA at nucleotide position 2608.  The resulting clone encodes a fusion 
protein consisting of the first 517 residues of pp60 c-sre fused to residues 
853-1052  of pp125 FAg.  A  similar  approach  was  used  to  generate  the 
2ASrcFATdl construct,  however, the amplified src eDNA  was ligated in 
frame to the Apal site of the FAK cDNA encoding the pp125 FAg mutant 
d1965-1012 containing the epitopc tag at the COOH terminus (see below). 
Two other variants of pp60  c-s~ were used. The first contains an amber mu- 
tation  at  amino  acid  residue  518  (termed  Sre518Am).  Expression  of 
Src518Am results in cellular transformation (Reynolds et al.,  1989).  The 
second variant contains the 518 amber mutation and the glycine to alanine 
substitution at amino acid residue 2 (termed 2ASrc518Am). The 2A muta- 
tion abrogates the transforming potential of activated Sre variants (Reynolds 
et al.,  1989). cDNAs encoding FAK, the FAK mutations, and Src-FAK fu- 
sion proteins were cloned into the retroviral vector RCAS A (BH). cDNAs 
encoding pp6(Y  >s~,  Sre518Am, and 2ASre518Am were cloned into RCAS 
a  (BH). 
Epitope-tagged pp125 FAK was generated using the pBluescript deriva- 
tive  pctag  as  previously  described  (Schaller  et  al.,  1993).  Similarly, 
epitope-tagged FAK variants were created by subeloning into pctag contain- 
ing the full length FAg" cDNA.  The epitope tag consists of the final  11 
COOH-terminal residues of SV40 large T antigen (KPPTPPPEPET).  In the 
tagged constructs, the epitope replaces the final 13 COOH-terminal resi- 
dues of FAK variants expressed. The 11 residue epitope tag is specifically 
recognized by the mAb KT3  (Mac.Arthur and Walter,  1984). 
Protein Expression and Analysis 
Cells were lysed in modified radioimmunoprecipitation assay buffer (Kan- 
ner et al.,  1989), protein concentration determined by BCA protein assay 
(Pierce, Rockford, IL), and the lysates evaluated directly or used for immu- 
noprecipitation as previously described (SchaUer et al.,  1992).  Total ceil 
lysates or  immune complexes  were  subjected  to SDS-PAGE  (Laemmli, 
1970) and immunoblotted for the detection of FAK and FAK variants, Src 
and Sre variants, and pTyr.  The FAK-specific polyvalent serum BC3 has 
been described previously (Schaller et al., 1992). The FAK-specific polyva- 
lent serum BC1 was raised against a bacterially expressed trpE-FAK fusion 
protein (Koerner et al.,  1991) containing residues 311-701  of FAK. Immu- 
noprecipitation and Western blot detection of Sre and Sre derivatives was 
performed using the mouse mAb EC10 (Parsons et al., 1984). Western blot 
detection of tyrosine phosphorylated proteins was carried out as described 
previously using affinity-purified rabbit antibodies specific for pTyr (Kanner 
et al.,  1990). For in vitro kinase assays, BC3 immune complexes or ECI0 
immune complexes were incubated for 15 rain at room temperature in FAK 
kinase buffer (10 mM Pipes [pH 7.2], 3 mM MnCI2) or Sre kinase buffer 
(20  mM  Pipes  [pH  7.2],  10  mM  MnC12)  plus  10  #Ci  [')'-32p]ATP 
(Dupont/New England Nuclear, 6000 Ci mmole  -1) (SchaUer et al.,  1992; 
Bryant and Parsons, 1984) and the complexes visualized by SDS-PAGE and 
autoradiography. 
Immunofluorescence 
Immunofluorescence experiments were carried out as previously described 
(Reynolds et al., 1989; Wu et al., 1991). FAK variants and Sre variants were 
detected  with  mAbs  KT3  or  EC10,  respectively,  affinity  purified  goat 
anti-mouse secondary antibody, and FITC-conjugated donkey anti-goat ira- 
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Results 
Expression of  ppl2M  Ar Variants 
A mutational analysis of pp125 F^K was initiated to identify 
regions of  the protein that mediate various aspects of its func- 
tion, including subcellular localization and regulation of its 
enzymatic activity. Epitope-"tagged" FAK variants bearing 
either deletions or a Lys to Arg point mutation within the 
ATP-binding site of the catalytic domain (lCmighton et al., 
1991;  Hanks et al.,  1988)  were generated as described in 
Materials and Methods (Fig. 1). Cells overexpressing either 
pp125 FAK or FAK variants retained a  normal cellular mor- 
phology (data not shown). To assess the level of FAK protein 
expression and the extent of in vivo tyrosine phosphoryla- 
tion, transfected cells were lysed and FAK proteins immuno- 
precipitated using the FAK-specific polyvalent serum BC3. 
Analysis of immune complexes by Western blot  analysis 
using BC3 (Fig. 2 a) or anti-pTyr antibody (Fig. 2 b) con- 
firmed both the expression and tyrosine phosphorylation of 
polypeptides of the correct predicted molecular weight. Ex- 
pression of endogenous pp125 FAt was readily detected by 
BC3 Western blot upon longer exposure of the autoradio- 
graphs  (data  not shown).  Interestingly, the expression of 
d151-377 (a, lane 8) resulted in the appearance of two BC3 
immunoreactive proteins of m83 and 87 kD. We speculate 
that the additional polypeptide may be generated by alterna- 
tive translational initiation or proteolytic cleavage of NH2- 
terminal sequences. Also evident is the attenuated expres- 
sion of d131-144, which was reproducibly diminished rela- 
tive to the expression of other variants (a, lane 7; see also 
Figs. 3 and 4). The altered expression of this variant did not 
appear to reflect incomplete infection of the cells, as these 
cells were resistant to  superinfection by a  transformation 
competent virus of the same subgroup (data not shown). 
This suggests the possibility that deletion of NH2-terminal 
sequences may either increase the rate of mutant protein 
degradation or inhibit the rate of protein synthesis. Finally, 
BC3 immunoprecipitation and Western blotting of extracts 
from cells transfected with d1686-1011 yielded little detect- 
able signal (a, lane 12). However, since this mutation deletes 
the majority of the sequences used to generate the BC3 an- 
tisera, extracts were immunoprecipitated and immunoblot- 
ted with a  second polyvalent sera, BC1, which is directed 
against the FAK kinase domain. As shown in Fig. 2, BC1 rec- 
oguized a polypeptide of correct predicted molecular weight 
that  was  phosphorylated on  tyrosine  (a  and  b,  lanes  15 
and 17). 
Anti-pTyr Western blotting of immune complexes pre- 
pared in parallel, indicated that each of the deletion variants 
was phosphorylated on tyrosine in vivo, and the pTyr signal 
was proportional to the level of protein expression. As ex- 
pected,  the  predicted  kinase  deficient variant  pmK454R 
showed significantly reduced levels of tyrosine phosphoryla- 
tion (b, lane 13). The low level of tyrosine phosphorylated 
FAK protein observed in Be3 immune complexes from cells 
expressing pmK454R was similar to that present in immune 
complexes from mock- or vector-transfected cells, and was 
consistent with the presence of endogenous pp125 F^K in the 
immune complex. This observation implies that the majority 
of tyrosine phosphorylation of FAK in vivo is primarily the 
consequence of autophosphorylation and not transphosphor- 
ylation by other cellular protein tyrosine kinases. 
To assess the in vivo kinase activity of the pp125 FAK mu- 
tants, total cell lysates from transfected cells were analyzed 
for pTyr-containing proteins by anti-pTyr Western blotting 
(Fig.  3).  In each case,  overexpression of pp125 FAK or in- 
dividual FAK variants did not result in a significant increase 
in tyrosine phosphorylation of cellular proteins, indicating 
that none of the deletions deregulate FAK catalytic activity 
and lead to unscheduled tyrosine phosphorylation of cellular 
proteins. 
The in vitro kinase activity of individual FAK variants was 
Figure  1.  Diagrammatic 
representation  of  pp125  FA~, 
p41FRNK, and  pp125  F^K vari- 
ants.  The  NH2-terminal do- 
main  is  represented  by  the 
black region, the kinase do- 
main by  the  shaded region, 
and the COOH-terminal do- 
main  by  the  white  region. 
Filled  circles indicate the 
presence and position of the 
epitope tag. Internal deletions 
were generated using specific 
restriction enzymes and modi- 
fying enzymes as described in 
Materials and Methods. The 
subcellular  localization  and 
enzymatic  activity  of  each 
variant is indicated at the right 
(+  indicating focal adhesion 
localization or enzymatic ac- 
tivity as measured by in vitro 
kinase assay, respectively). 
Hildebrand et al. FAK Localization of Focal  Adhesions  995 Figure 3. Phosphorylation state of cellular proteins. Cell lysates (50 
/zg) from control cells or cells expressing the various FAK cDNAs 
were subjected to SDS-PAGE and the samples analyzed by Western 
blotting with anti-pTyr. 
dogenous pp125 FA~, confirming that this mutant is enzymat- 
ically inactive. 
Subcellular Localization of  ppl25  rA~ Mutants 
Our  previous  results  indicate  that  both  FAK  and  FRNK 
localize to focal adhesions (Schaller et al.,  1993), suggesting 
that the sequences responsible for localization reside within 
the  COOH-terminal  one-third  of pp125 FAK. To more  thor- 
oughly  identify  the  FAK  sequences  required  for targeting 
FAK to focal adhesions,  the  subcellular  localization  of in- 
dividual FAK variants was assessed (Fig.  5).  To distinguish 
between endogenous and exogenously expressed FAK, cells 
Figure 2.  Expression  and  tyrosine phosphorylation  of pp125 FAK 
and pp125 FAK variants. The cDNAs encoding FAK or FAK variants 
were cloned into the RCAS A (BH) retroviral vector and expressed 
in CE cells.  Cell lysates (500/~g) from control cells or cells trans- 
fected with the various constructs were evaluated by immunopre- 
cipitation using polyvalent serum BC3 (a and b, lanes 2, 4, and 
6-13) or BC1 (a and b, lanes 15 and 17). Immunoprecipitates were 
divided in half and analyzed by Western blotting using BC3  (a, 
lanes 1-13), BC1  (a, lanes 14-17),  or anti-pTyr (b).  Control im- 
munoprecipitations were carried out in parallel using preimmune 
serum (PI, a and b, lanes 1, 3, 5, 14, and 16). Retroviral constructs 
used  are  listed  across  the  top,  where Mock,  mock transfected; 
RCAS, empty vector; and FAK, wild-type pp125 FAK. 
measured  using  an in  vitro immune  complex  kinase  assay 
(Fig. 4). BC3 immune complexes containing  individual de- 
letion  variants  exhibited  greatly  elevated autophosphoryla- 
tion activity in comparison to the activity of BC3  immune 
complexes from control cells.  This elevated level of kinase 
activity detected in vitro correlated with the level of protein 
expression.  The  point  mutant  pmK454R  showed  only  a 
background level of activity (Fig. 4, lane 13), comparable to 
that observed in control immune complexes containing  en- 
Figure 4.  In vitro kinase activity of pp125 F^~ variants.  BC3  im- 
mune complexes (lanes 2, 4, and 6-13) from control cells and cells 
expressing  the  various  pp125 FAK  retroviral  constructs  were  in- 
cubated in kinase buffer and [3,-32P]ATP, subjected to SDS-PAGE, 
and  visualized  by autoradiography.  Control  immune  complexes 
using preimmune serum were performed in parallel  (lanes  1,  3, 
and 5). 
The Journal of Cell Biology, Volume 123, 1993  996 Figure 5. Immunostaining of NH2-terminal, COOH-terminal, and kinase defective FAK variants. CE cells expressing epitope-tagged vari- 
ants of d131-144 (a), d151-377 (b), d1686-1011 (c), and pmK454R (d) were grown overnight on glass coverslips, fixed, and immunostained 
with mAb KT3 as described in Materials and Methods. Bar, 3.5 #m. 
expressing epitope-tagged variants of FAK were immuno- 
stained  with  mAb  KT3.  Cells  expressing  epitope-tagged 
variants  d131-144 (Fig.  5  a),  d151-377  (Fig.  5  b),  or 
pmK454R (Fig. 5 d) exhibited characteristic focal adhesion 
staining upon incubation with mAb KT3. In contrast, little 
or no staining of focal adhesion structures was observed in 
cells expressing the COOH-terminal deletion variant d1686- 
1011 (Fig. 5 c). These data not only support earlier findings 
which indicate that the FAT sequence is  contained in the 
COOH-terminal  domain  of FAK,  but also  imply that  the 
NH2 terminus is  not required for focal adhesion localiza- 
tion. Furthermore, the presence of kinase deficient FAK in 
focal adhesions indicates that kinase activity is not a neces- 
sary prerequisite for translocation of  FAK to focal adhesions. 
To further define the sequences necessary to mediate the 
localization  to  focal  adhesions,  three  additional  COOH- 
terminal deletion variants of FAK were analyzed (Fig.  6). 
Cells  expressing  epitope-tagged  d1721-857, when  stained 
with mAb KT3, exhibited extensive focal adhesion structures 
(Fig. 6 a). In contrast, mAb KT3 immunostaining of cells 
expressing either epitope-tagged d1853-963  or d1965-1012 
revealed a punctate cytoplasmic fluorescence (Fig. 6, c and 
e, respectively). Costalning of these cells with an antibody 
directed to the focal adhesion protein talin revealed a distinc- 
tive focal adhesion staining pattern,  confirming that these 
cells retain intact adhesion structures (Fig. 6, d and f). The 
immunostaining experiments clearly indicate that the FAT 
sequence resides within or overlaps the 159 residues between 
amino acid positions 853 and  1012. 
Focal Adhesion Localization of a Cytosolic Protein 
Having demonstrated that FAK residues 853-1012 contain a 
Hildebrand et al. FAK Localization of Focal Adhesions  997 Figure 6. Fine mapping of pp125  FAK COOH terminus. CE cells expressing epitope-tagged variants d1721-857  (a and b), d1853-963 (c and 
d), or d1965-1012 (e and  f) were grown overnight on glass coverslips, fixed, and costained with mAb KT3 (a, c, and e) and a rabbit polyva- 
lent serum specific for talin (b, d,  and f) as described in the Materials and Methods. Bar, 3.5 #m. 
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tation of c-Sic, Sic variants, 
and  Src-FAK fusions. The 
eDNA encoding pp60  ~-src was 
modified to encode four vari- 
ants.  Point  mutations  in 
codons 2 and 518 result in the 
generation of a glycine (Gly2) 
to alanine (Ala2) substitution 
mutation and an amber non- 
sense  mutation  (518Am), 
respectively.  Myristylation 
and  transforming activity of 
each individual  variant is indi- 
cated at right (see text for dis- 
cussion of the phenotype in- 
duced by each varian0. 
major determinant for pp125 F^K localization to focal adhe- 
sions,  we sought to determine if the FAT sequence could 
function as a localization domain if placed in the context of 
a cytoplasmic protein. The portion of the FAK  eDNA encod- 
ing the FAT sequence was ligated to the eDNA encoding an 
activated variant of pp60  '~ containing a Gly to Ala muta- 
tion at position 2 (Fig. 7). This mutation removes the NH2- 
terminal myristylation site of pp60," and consequently the 
mutant Src protein is  cytosolic in contrast to the normal 
membrane-associated  wild-type pp60  '~  (Reynolds et  al., 
1989).  The resulting Src-FAK fusion protein,  2ASrcFAT, 
contains the first 517 residues of pp60  '~ fused to the final 
199  amino acids of pp125 F^K. 2ASrcFAT  was cloned into 
RCAS A (BH) and transfected into CE cells in parallel with 
three additional Src variants (Fig. 7). The subcellular local- 
ization of the overexpressed Src variants was assessed by 
dual immunofluorescence staining employing the pp60  '~- 
specific mouse mAb EC10 and a rabbit antiserum directed 
against the focal adhesion associated protein talin (Fig. 8). 
Staining of cells expressing pp60  ~  with rnAb EC10 showed 
predominantly  membrane  and  perinuclear  fluorescence, 
whereas  the  anti-talin  antibodies  stained  focal  adhesions 
(Fig. 8, a and b). Cells expressing 2ASrc518Am exhibit pri- 
marily cytoplasmic fluorescence with mAb EC10, while the 
anti-talin antibodies stained focal adhesion structures (Fig. 
8, c and d). There appeared to be fewer well formed focal 
adhesion structures in cells expressing 2ASrc518Am than in 
those cells expressing c-Src, probably due to the altered cel- 
lular morphology that results from 2ASrc518Am  deregu- 
lated kinase activity (see below). Cells expressing 2ASrcFAT 
exhibited extensive staining of focal adhesions with both 
EC10  and  anti-talin  (Fig.  8,  e  and f).  The  targeting  of 
2ASrcFAT to focal adhesions was dependent upon the intact 
FAT sequence since cells expressing 2ASrcFATdl  (lacking 
the FAT sequence) exhibited primarily cytoplasmic fluores- 
cence with EC10,  while anti-talin revealed extensive focal 
adhesion staining (Fig. 8, g and h). These data establish that 
addition of the FAT sequence to a cytosolic protein appears 
sufficient to target the protein to cellular focal adhesions. 
Kinase Activity of  Focal Adhesion 
Targeted Src Variants 
We  anticipated that targeting an  activated Src  variant to 
cellular  focal adhesions might lead  to enhanced tyrosine 
phosphorylation of some cytoskeletal components and sub- 
sequent  alterations  in  cellular  phenotypes  as  previously 
reported (Liebl and Martin,  1992).  Since cellular transfor- 
marion was not readily evident, we sought to examine the in 
vivo enzymatic activity of the Src variants 2ASrcFAT  and 
2ASrcFATdl. To evaluate the in vivo catalytic activity, total 
cell lysates were analyzed directly by anti-pTyr Western blot- 
ting  (Fig.  9  a).  Mock and vector-alone transfected cells 
showed  only a  125-kD  tyrosine phosphorylated protein. 
Cells  expressing  c-Src  contained two  tyrosine phosphor- 
ylated proteins, presumably pp125 F'~ and pp60  ~-~ (a, lane 
3). In contrast, cells expressing 2ASrc518Am and Src518Am 
contained numerous tyrosine phosphorylated cellular pro- 
teins (a, lanes 4 and 5, respectively), consistent with previ- 
ous observations (Reynolds et al., 1989). However, cells ex- 
pressing 2ASrcFAT  and 2ASrcFATdl  exhibited a  severely 
restricted repertoire of  tyrosine phosphorylated cellular pro- 
teins (a, lanes 6 and  7,  respectively). The major tyrosine 
phosphorylated proteins  appear  to be the fusion proteins 
themselves and  a  protein  of similar molecular weight to 
pp125 F^K. These data indicate that neither of the Src-FAK 
fusion proteins exhibit the ability to phosphorylate cellular 
proteins as efficiently as either Src518Am  or 2ASrc518Am. 
As  shown  in  Fig.  9,  tyrosine  phosphorylation  of 
2ASrcFATdl  was  modest  compared  to  that  observed  for 
2ASrcFAT (a, lanes 6 and 7). Therefore, the level of expres- 
sion and activity of  individual fusion proteins were examined 
(Fig. 9, b and c). The Src variants and the Src-FAK fusion 
proteins  were  immunoprecipitated  using  EC10  and  the 
immune complexes analyzed by EC10  immunoblotting or 
in  vitro  kinase  assay.  Western  blot  analysis  indicated 
that 2ASrcFATdl  was  expressed  at a  level  ,v20%  that of 
2ASrcFAT (b, lanes 6and 7). In vitro kinase assays indicated 
that  each  of the proteins  was  enzymatically active,  with 
2ASrcFAT and 2ASrcFATdl exhibiting in vitro activity com- 
parable to the degree of expression (b and c, lanes 6 and 7, 
respectively). 
The lack of tyrosine phosphorylation of cellular proteins 
in 2ASrcFAT and 2ASrcFATdl over-expressors indicates that 
the addition of sequences to the COOH terminus of Src may 
render it incapable of phosphorylating certain cellular pro- 
teins that are normally phosphorylated by Src518Am and 
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2ASrcFAT (e and f), and 2ASrcFATdl (g and h) were grown overnight on glass coverslips, fixed, and costained with mAb EC10 (a, c, 
e, and g) and anti-talin rabbit polyvalent serum (b, d, f, and h) as described in Materials and Methods. Bar, 3.5 /zm. 
2ASrc518Am. For example, the low in vivo enzymatic activ- 
ity exhibited by 2ASrcFAT and 2ASrcFATdl may result from 
steric inhibition of the catalytic activity of the kinase by in- 
tramolecular interactions between the FAT sequence and the 
NH2 terminus of Src or intermolecular interaction between 
the FAT sequence and another cellular protein. 
Discussion 
The complex architecture of cellular focal adhesions is de- 
pendent upon numerous defined protein-protein interactions 
between focal adhesion components (Burridge et al.,  1988; 
Turner and Burridge, 1991). However, the mechanisms and 
cellular components regulating these association events are 
unknown.  Here we report the identification of the FAT se- 
quence of pp125  ~Az. The FAT sequence resides in the distal 
199  COOH-terminal  residues  of pp125 FAK and is  required 
for efficient localization to focal adhesions. The presence of 
tyrosine phosphorylated proteins in  focal adhesions (Bur- 
ridge et al.,  1992; Guan et al.,  1991) and the regulation of 
tyrosine phosphorylation of these proteins in response to cell 
adhesion and spreading (for review see Juliano and Haskal, 
1993; Schaller et al.,  1993) makes pp125 FAK a prime candi- 
date for a  regulatory component of focal adhesion assem- 
bly/disassembly as well as a possible mediator of signaling 
to the nucleus. 
Experimental  analysis  of most  focal  adhesion  proteins 
suggests that the subcellular localization of these proteins is 
dependent upon specific protein-protein interactions. Inves- 
tigation  and  identification of functional domains  of focal 
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adhesion proteins has relied primarily upon the biochemical 
study of purified  focal adhesion proteins  and proteolytic 
fragments of purified focal adhesion components (Pavalko 
and Burridge, 1991; Otey et al.,  1990;  Turner et al.,  1990; 
Sadler et al.,  1992;  Nuckolls et al.,  1990;  Horwitz et al., 
1986). Conversely, we have used a mutational analysis to in- 
vestigate the domain structure of pp125 FA~ and identify the 
regions that determine subcellular localization. Deletion of 
virtually the entire NH: terminus had no apparent conse- 
quence upon the localization of pp125 FAK. In contrast, small 
adjacent deletions of either 110 (d1853-963)  or 47 (d1965- 
1012) amino acid residues in the COOH terminus abolished 
focal adhesion localization, resulting in cytosolic variants. A 
polypeptide containing residues 853-1052,  when fused in 
frame to the COOH terminus of a normally cytosolic pro- 
tein, was capable of mediating focal adhesion localization. 
Therefore, this sequence directs FAK to focal adhesions and 
presumably contains a  site that may mediate specific pro- 
tein-protein interaction(s) between pp125 ~AK and other fo- 
cal adhesion components. Efforts are underway to identify 
the FAK-binding protein present in focal adhesions. We pre- 
dict, that this protein may be a relatively abundant protein, 
since  overexpression  of pp125 F^K  ('~10-fold)  results  in  a 
significant increase in focal adhesion staining. Hence, either 
focal adhesions contain an abundance of FAK-binding sites 
or FAK is capable of self-association, forming higher order 
aggregates in focal adhesions. 
The use of specific protein-protein or protein-membrane 
interactions to target protein tyrosine kinases to predeter- 
mined cellular compartments is well documented. The Abl 
protein  tyrosine kinase contains an actin-binding domain 
within its COOH terminus (McWhirter and Wang, 1993) and 
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and Sre-FAK fusion proteins.  To measure  in vivo tyrosine phos- 
phorylation, total cell lysates (50/~g) from control ceils or ceils ex- 
pressing the various Src and Sre-FAK proteins were subjected to 
SDS-PAGE  and the samples analyzed by Western blotting with anti- 
pTyr (a). To measure expression level and in vitro catalytic activity 
of Src proteins, cell lysates (500 tzg) from control ceils or cells ex- 
pressing Src, Src variants, or Sre-FAK fusion proteins were sub- 
jected to immunoprecipitation  using the Src-specific mAb EC10. 
For each sample, one half of the immune complexes were analyzed 
by Western blotting using ECl0 (b). The remainder of the immune 
complexes were incubated in kinase buffer plus  [3~-32p]ATP, sub- 
jected to SDS-PAGE, and visualized by autoradiography  (c). 
this domain appears to be critical for both the normal func- 
tion of c-Abl (Henkemeyer et al., 1990; Schwartzberg et al., 
1991; Tybulewicz et al., 1991) and the transforming potential 
of the oncoprotein Bcr-Abl (McWhirter and Wang,  1993). 
The N-myristylation site  of pp60  s~  is  required  for mem- 
brane association and is essential for the oncogenic potential 
of v-Src (Parsons and Weber, 1989), and presumably for the 
normal function of its cellular homologue, c-Src (Bagrodia 
et al., 1993; Reynolds et al., 1989). Therefore, we speculate 
that the interaction of pp125  F~ with a  specific focal adhe- 
sion protein  may be essential  for placing pp125  F^K in  the 
correct cellular compartment, in close proximity to potential 
regulator and effector molecules. 
Our results indicate that autophosphorylation is the pri- 
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FAK autophosphorylation in regulating its cellular function 
is unknown. It is clear, however,  that autophosphorylation 
plays no role in targeting FAK to focal adhesions since an 
enzymatically inactive variant of FAK properly localizes to 
focal adhesions. Recently we have demonstrated the stable 
association between FAK and activated variants of pp60  ~ 
in  Src  transformed cells and the association of FAK and 
c-Fyn in normal CE cells. The stable association of these ki- 
nases is dependent upon both phosphorylation of FAK and 
an intact Src SH2 domain (Cobb et al., 1994). We have pro- 
posed that the autophosphorylation of FAK may serve to 
recruit Src-family kinases or concomitantly other SH2-con- 
taining proteins, such as tensin (Davis et al., 1991), to focal 
adhesions. The investigation and identification of the auto- 
phosphorylation site, the role autophosphorylation may play 
in regulating enzymatic activity, and the possible transphos- 
phorylation of pp125 FAK will provide additional clues to the 
functional significance of these interactions. 
The ability of p41 ~NK and pmK454R, both of which are 
catalytically  inactive, to localize to focal adhesions raises the 
possibility that  either protein  may  function in  dominant 
negative fashion by occupying all of the potential binding 
sites for enzymatically active pp125 rAK. To date,  we have 
little data to suggest that overexpression of either FRNK or 
pmK454R  effects  normal cellular morphology or growth 
(data not shown; Schaller et al.,  1993).  One might predict 
that exclusion of pp125 F^K enzymatic activity from focal 
adhesions might alter cellular functions predicted to be de- 
pendent upon focal adhesions such as cell spreading and 
migration. The apparent lack of phenotype associated with 
cells overexpressing pmK454R or FRNK suggests that lo- 
calization to focal adhesions may not be sufficient to inter- 
fere with integrin coupled signaling. Preliminary microin- 
jection  experiments  using  a  mAb  directed  to  the  FAT 
sequence  indicate that pp125 FA~ is  intimately involved in 
cellular function. Cells injected with the mAb 2A7 (Karmer 
et al., 1990) do not spread after trypsinization and replating 
onto fibronectin (Schwartz,  M.  A., personal communica- 
tion). These observations implicate FAK as a critical regula- 
tor of cell spreading and support the model that FAK must 
localize to focal adhesions to be functionally active. 
The localization of an activated variant of Src, 2ASrcFAT, 
to  cellular  focal  adhesions  did  not  result  in  significant 
changes in cell morphology and growth although the infected 
cells grew in a disorganized manner compared to normal CE 
cells  (data  not  shown).  Our  data are  in  contrast  to  that 
reported by Liebl and Martin (1992),  who reported that fu- 
sion of the focal adhesion targeting domain of vinculin to the 
NH: terminus of activated Src resulted in cell transforma- 
tion.  The experimental differences may reflect the conse- 
quences of using different  domains to target proteins to focal 
adhesions.  For example,  addition of targeting domains to 
NH2- or  COOH-terminal  regions  of Src  may orient  the 
catalytic domains differently, exposing the Src kinases to 
different cellular substrates.  Similarly, vinculin and FAK 
may localize to different subcompartments within a  focal 
adhesion. This may be a critical parameter in the transform- 
ing potential, such that the catalytic domain may be more 
readily available to interact with cellular substrates when in 
the position normally occupied by vinculin than when in the 
position normally occupied by FAK. 
Oncogenic transformation induced by most tyrosine ki- 
nases depends upon deregulated enzyme function, usually 
arising from the deletion or disruption of specific regulatory 
elements contained within the kinase itself. This paradigm 
applies to the oncogenic activation of both receptor and non- 
receptor tyrosine kinases (for review see Cantley et al., 1991; 
Ullrich and Schlessinger, 1990). In the case of v-erb-B, dele- 
tion of the extracellular ligand-binding domain removes the 
inhibitory function this structure normally imposes upon the 
cytoplasmic kinase domain (Downward et al., 1984). In the 
proto-oncogene encoded forms of Src and Src-like kinases 
(Cantley et al.,  1991; Parsons  and Weber,  1989),  phos- 
phorylated tyrosine residues located at the extreme COOH 
terminus of the protein interact with SH2 domains located 
just NH2-terminal  of the catalytic domain, functioning to 
maintain the kinase in an inactive state (Cantley et al., 1991; 
Cooper and Howell,  1993).  In Src and Src-like oncopro- 
teins transduced by retroviruses, these regulatory tyrosine 
residues are deleted, thus abolishing the inhibition. In the ex- 
amples of both v-erb-B  and Src-like kinases, disruption of 
the regulatory elements leads to the constitutive activation 
of these enzymes. In the case of Src, activation of enzyme 
activity is mirrored by a dramatic elevation in the tyrosine 
phosphorylation of other cellular proteins, presumably the 
effector molecules, and subsequent cellular transformation 
(Reynolds et al., 1989). FAK does not appear to fit the model 
set forth by either the Src-like kinases or the receptor tyro- 
sine  kinases.  In  the  case  of pp125 FAK, deletion of either 
NH2- or  COOH-terminal  sequences  does  not  appear  to 
deregulate the catalytic activity of the FAK protein, as evi- 
denced by the lack of  elevated levels of  tyrosine phosphoryla- 
tion in ceils expressing these variants. In accord, cells over- 
expressing pp125 F^K or deletion variants of pp125 F^K have 
normal growth properties and are not morphologically trans- 
formed, It is possible that the transforming capacity of FAK 
and FAK variants is negated by either the activity of cellular 
phosphatases, a narrow substrate specificity, or some other 
unidentified cellular mechanism. 
Several  cytosolic  tyrosine  kinases  have  recently  been 
identified as signaling components of cell surface receptors 
that themselves contain no identified intrinsic enzymatic ac- 
tivity. These include the T cell receptor, the high affinity Fc 
receptor for immunoglobulin (for review see Weiss, 1993), 
and the interferon t~//$ receptors (Velazquez  et al.,  1992). 
These  kinases,  including  ZAP-70  (Chan  et  al.,  1992), 
p72sy  k (Hutchcroft et al.,  1991; Taniguchi et al., 1991), tyk2 
(Velazquez et al.,  1992;  Firmbach-Kraft et al.,  1990),  and 
JAK-1 and JAK-2  (Wilks  et al.,  1991), like pp125 F^K, are 
structurally distinct from the Src family of protein tyrosine 
kinases and the receptor tyrosine kinases. Also like FAK, the 
mechanism by which these kinases are regulated to coor- 
dinately receive and transmit signals is unknown. These cy- 
toplasmic kinases may not possess obvious negative regula- 
tory  domains  such  as  those  in  the  Src-family  kinases. 
Therefore,  the  regulation  of FAK may be  more  closely 
related to these cytosolic kinases than to the Src-like protein 
tyrosine kinases or the receptor tyrosine kinases. The FAK 
mutants described here should prove invaluable in the eluci- 
dation of the mechanism by which FAK is regulated. 
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